PD-1/PD-L1 inhibitors
Grant
US12590062B2
Kind: B2
Mar 31, 2026
Assignee
Gilead Sciences, Inc.
Inventors
Evangelos Aktoudianakis, Todd Appleby, Aesop Cho, Zhimin Du, Michael Graupe, Juan A. Guerrero, Salman Y. Jabri, Lateshkumar Thakorlal Lad, Paulo A. Machicao Tello, Jonathan William Medley, Samuel E. Metobo, Prasenjit Kumar Mukherjee, Devan Naduthambi, Gregory Notte, Eric Q. Parkhill, Barton W. Phillips, Scott Preston Simonovich, Neil H. Squires, Chandrasekar Venkataramani, Peiyuan Wang, William J. Watkins, Jie Xu, Kin Shing Yang, Christopher Allen Ziebenhaus
Abstract
Compounds according to formula (I), methods of using said compounds singly or in combination with additional agents and compositions of said compounds for the treatment of cancer are disclosed.
CPC Classifications
A61K 31/5377
A61K 31/44
A61K 31/444
A61K 31/4545
A61K 31/497
A61K 45/06
C07D 213/85
C07D 295/088
C07D 491/107
C07D 401/12
C07D 405/12
C07D 413/12
C07D 213/69
C07D 213/30
C07D 213/61
C07D 213/64
C07D 401/04
C07D 401/14
C07D 405/14
C07D 487/08
C07D 487/10
C07D 498/04
C07D 519/00
C07D 417/14
C07D 487/04
C07D 471/04
A61P 35/02
A61P 35/00
Filing Date
2020-11-13
Application No.
17098171
Claims
18